AKTIENANLEIHE - PFIZER INC | Market Closed - Deutsche Boerse AG 18:45:55 10/05/2024 BST | ||
| 94.5 USD | -0.17% |
|
| Current month | +7.96% | ||
| 1 month | +5.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 94.5 | -0.17% | 0 |
| 09/05/24 | 94.66 | +0.56% | 0 |
| 08/05/24 | 94.13 | +0.63% | 0 |
| 07/05/24 | 93.54 | -0.25% | 0 |
| 06/05/24 | 93.77 | +1.30% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 06:45 pm
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VM0FFL |
| ISIN | DE000VM0FFL3 |
| Date issued | 31/07/2023 |
| Strike | 28.82 $ |
| Maturity | 20/09/2024 (133 Days) |
| Parity | 0.03 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 99.97 $ |
|---|---|
| Lowest since issue | 86.63 $ |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01
USD
Average target price
31.94
USD
Spread / Average Target
+14.02%
- Stock Market
- Certificates
- Certificat
